Recommended Conferences

  • Advances in Neurology and Neuropsychiatry
    August 27-28, 2018 Tokyo, Japan
  • Psychiatry & Mental Health
    September 14-15, 2018 Singapore
  • Advances and Innovations in Dementia
    September 17-18, 2018 Singapore
  • Neurology and Cognitive Neuroscience
    October 18-19, 2018 Warsaw, Poland
  • Depression, Anxiety and Stress Management
    November 05-06, 2018 Bangkok, Thailand
  • Bipolar Disorder: Psychiatry and Mental Health
    November 5-7, 2018 Abu Dhabi, UAE

Dr. Tohru Hasegawa

Dr. Tohru Hasegawa Dr. Tohru Hasegawa
Associate professor of public health, Saga Medical School, Japan.
I got the Ph.Doctor degree of public health of Medical school, Okayama University. I worked in Saga Medical School as an associate professor of public health. At that time, I was interested in the anti-Alzheimers effect of Japanese green tea, which showed the decreasing effect on homocysteine in blood. However homocysteine did not show any neurodegenerative effect at its physiological dose. Why does Japanese green tea show the anti- Alzheimers effect? Finally I found that the pathogenic effect of homocysteic acid (HA), an oxidizing metabolite of homocysteine, on the cognitive decline of AD. Now I have developed the supplement which can decrease HA in blood. This supplement could recover the final stage of AD patients. They could recognize their families and enjoy their conversation with their families. I think our hypothesis that the HA in blood could be decrease to recover the cognition should be considered.
Research Interest
The pathogenic effect of homocysteic acid in blood of Alzheimers, neurodegeneration and cancer proliferation.

Relevant Conferences